Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

Presentation EuroPCR 2016

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

Presenter: Bernando Cortese

May 23, 2016

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation EuroPCR 2016

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

Presenter: Patrick Serruys

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

Presentation EuroPCR 2016

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

Presenter: Anna Franzone

May 19, 2016

Presentation EuroPCR 2016

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Presenter: Danny Dvir

May 19, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

Presentation EuroPCR 2016

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Presenter: Martin Bergmann

May 18, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Presentation EuroPCR 2016

A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study

Presenter: Tzung-Dau Wang

May 18, 2016

Presentation EuroPCR 2015

ILUMIEN II: A Retrospective Evaluation of Stent Expansion with OCT Guidance vs IVUS Guidance

Presenter: Gregg Stone

May 22, 2015

Presentation EuroPCR 2015

Two-year results in the Nordic-Baltic bifurcation study IV

Presenter: Indulis Kumsars

May 21, 2015

Presentation EuroPCR 2015

Computed tomographic angiography follow-up and 12-month outcome following balloon angioplasty for isolated penile artery stenoses in patients with erectile dysfunction: the PERFECT-2 study

Presenter: Tzung-Dau Wang

May 20, 2015

Presentation EuroPCR 2015

The NOTION Trial

Presenter: Lars Sondergaard

May 19, 2015

Presentation EuroPCR 2015

The FFR-CT RIPCORD Study

Presenter: Nick Curzen

May 19, 2015

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

Presentation EuroPCR 2015

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Presenter: Masahiro Natsuaki

May 19, 2015

Advertisement

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study

ILUMIEN II: A Retrospective Evaluation of Stent Expansion with OCT Guidance vs IVUS Guidance

Two-year results in the Nordic-Baltic bifurcation study IV

Computed tomographic angiography follow-up and 12-month outcome following balloon angioplasty for isolated penile artery stenoses in patients with erectile dysfunction: the PERFECT-2 study

The NOTION Trial

The FFR-CT RIPCORD Study

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content